Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 1
2007 2
2008 2
2009 1
2010 3
2011 9
2012 9
2013 9
2014 11
2015 22
2016 20
2017 15
2018 10
2019 18
2020 16
2021 18
2022 23
2023 16
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean seung hye choi (38 results)?
Effect of Dietary Habits on Alzheimer's Disease Progression.
Ahn SH, Jeong JH, Park KW, Kim EJ, Yoon SJ, Yoon B, Jang JW, Minn Y, Choi SH. Ahn SH, et al. Among authors: choi sh. Yonsei Med J. 2024 Apr;65(4):217-226. doi: 10.3349/ymj.2023.0119. Yonsei Med J. 2024. PMID: 38515359 Free PMC article.
SoUth Korean study to PrEvent cognitive impaiRment and protect BRAIN health through Multidomain interventions via facE-to-facE and video communication plaTforms in mild cognitive impairment (SUPERBRAIN-MEET): Protocol for a Multicenter Randomized Controlled Trial.
Cho SH, Kang HJ, Park YK, Moon SY, Hong CH, Na HR, Song HS, Choi M, Jeong S, Park KW, Kim HS, Chun BO, Jung J, Jeong JH, Choi SH. Cho SH, et al. Among authors: choi sh. Dement Neurocogn Disord. 2024 Jan;23(1):30-43. doi: 10.12779/dnd.2024.23.1.30. Epub 2024 Jan 29. Dement Neurocogn Disord. 2024. PMID: 38362052 Free PMC article.
Effects of the multidomain intervention with nutritional supplements on cognition and gut microbiome in early symptomatic Alzheimer's disease: a randomized controlled trial.
Lee EH, Kim GH, Park HK, Kang HJ, Park YK, Lee HA, Hong CH, Moon SY, Kang W, Oh HS, Yoon HJ, Choi SH, Jeong JH. Lee EH, et al. Among authors: choi sh. Front Aging Neurosci. 2023 Nov 2;15:1266955. doi: 10.3389/fnagi.2023.1266955. eCollection 2023. Front Aging Neurosci. 2023. PMID: 38020771 Free PMC article.
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
192 results